Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmmerson Regulatory News (EML)

Share Price Information for Emmerson (EML)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.95
Bid: 1.90
Ask: 2.00
Change: 0.05 (2.63%)
Spread: 0.10 (5.263%)
Open: 1.90
High: 1.95
Low: 1.90
Prev. Close: 1.90
EML Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Commencement of ESIA Baseline Studies

12 Feb 2019 07:00

RNS Number : 6827P
Emmerson PLC
12 February 2019
 

 

Emmerson Plc / Ticker: EML / Index: LSE / Sector: Mining

12 February 2019

 

Emmerson Plc ("Emmerson" or the "Company") 

Commencement of ESIA Baseline Studies enables accelerated development at Khemisset potash project

 

Emmerson Plc ("Emmerson" or "the Company"), the Moroccan focused potash development company, is pleased to announce that it has commenced the Environmental and Social Impact Assessment ("ESIA") baseline study for its Khemisset Potash Project (''Khemisset" or "the Project").

The Company recently released a Scoping Study which demonstrated that Khemisset has a rare combination of low capital cost to production and among the highest EBITDA margins in the industry. This resulted in outstanding economic metrics, including a post-tax NPV10 of approximately US$1.1bn using industry expert (Argus FMB) price forecasts.

The ESIA baseline study is the initial workstream in the process of delivering a detailed ESIA, the key supporting document that will be delivered to the Ministry of Mines to convert Emmerson's exploration permits ("Permis de Recherche") to a Mining Licence ("Licence d'Exploitation").

Emmerson is committed to developing the Khemisset Project in accordance with the world's highest environmental standards. The ESIA will be structured and executed to adhere to the IFC Performance Standards and the Equator Principles, which act as guidelines for best practice in terms of environmental and stakeholder risk management and are generally required by debt financing institutions to achieve financial close.

Following a rigorous selection process, Moroccan headquartered firm Phénixa S.A.R.L ('Phénixa') has been appointed to manage the baseline study and develop the framework for the ESIA. The scope of work assesses the potential impacts of the Project on various aspects within the project area and include:

· Land uses, social settings, and habitat types

· Soil types, flora, and fauna

· Climate, topography & elevation

· Surface water, and ground water

· Archaeology, anthropology, and cultural heritage

Phénixa has a strong track record in the delivery of ESIAs to support approvals under the Moroccan regulatory framework, as well as for international financing requirements for mining projects. It has assisted several large-scale mining and energy projects in Morocco, including managing the ESIA process and the Environmental and Social Monitoring Program for the Achmmach Tin Project, owned by ASX listed Kasbah Resources Ltd.

 

Hayden Locke, CEO of Emmerson, commented:

"Commencing the environmental baseline studies represents a further development milestone at the Khemmiset project. The ESIA will be the key document underpinning our application for a Mining Licence for the Khemisset Project. We are using local consultants with extensive in country experience, having been involved in some of the largest projects in Morocco including recently delivering an ESIA and Environmental and Social Monitoring programs to support an application for a Mining Licence."

 "The outstanding results of the Scoping Study for Khemisset confirmed that Emmerson controls a potentially world-class development stage potash asset and has provided us with the confidence to commence the ESIA process now to ensure our accelerated development timeline remains achievable."

 

**ENDS**

For further information, please visit www.emmersonplc.com, follow us on Twitter (@emmerson_plc), or contact: 

Hayden Locke

Emmerson Plc

Tel: +44 (0) 207 236 1177

Edward McDermott

 

James Biddle

Roland Cornish

Beaumont Cornish Limited

Financial Adviser

 

Tel: +44 (0) 207 628 3396

 

Jeremy King

 

Optiva Securities Limited

Broker

Tel: +44 (0) 3137 1904

Gaby Jenner

Melissa Hancock

St Brides Partners Ltd

Financial PR/IR

Tel: +44 (0) 20 7236 1177

 

 

Notes to Editors

Emmerson's primary focus is on developing the Khemisset Potash Project located in Northern Morocco. The project has a large JORC Resource Estimate (2012) of 311.4Mt @ 10.2% K2O and significant exploration potential with an accelerated development pathway targeting a low capex, high margin mine. Khemisset is perfectly located to capitalise on the expected growth of African fertiliser consumption whilst also being located on the doorstep of European markets. This unique positioning means the project will receive a premium netback price compared to existing potash producers. The need to feed the world's rapidly increasing population is driving demand for potash and Emmerson is well placed to benefit from the opportunities this presents.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DRLTBMFTMBTBBFL
Date   Source Headline
24th May 20247:00 amRNS2023 Financial Results
22nd Apr 202411:47 amRNSTR-1: Notification of major holdings
8th Apr 20244:45 pmRNSResults of Oversubscribed REX Retail Offer
8th Apr 20247:01 amRNSREX Retail Offer
8th Apr 20247:00 amRNSQ1 Update, Equity Placing and Retail Offer
11th Mar 20247:00 amRNSCommittee Upholds Environmental Approval Referral
1st Feb 20247:00 amRNSScoping Study on Breakthrough New Processing Route
8th Jan 20247:00 amRNSQ4 Update
21st Dec 20237:00 amRNSExtension of Mandated Lead Arrangers
26th Sep 20237:00 amRNSInterim Results for the six months to 30 June 2023
21st Sep 20237:00 amRNSQ3 2023 and Financing update
11th Sep 202311:38 amRNSMorocco Statement
11th Jul 202311:57 amRNSDirector/PDMR Shareholding
10th Jul 20234:30 pmRNSDirector/PDMR Shareholding
6th Jul 20232:49 pmRNSDirector/PDMR Shareholding
6th Jul 20237:00 amRNSQ2 Update
6th Jun 20237:00 amRNSExercise & Allotment of Shares
31st May 202312:01 pmRNSResult of AGM
5th May 20237:00 amRNSNotice of AGM and Posting of Annual Report
13th Apr 20237:00 amRNS2022 Financial Results and Q1 Update
14th Feb 20237:00 amRNSMandated Lead Arrangers Appointed for Financing
9th Jan 20237:00 amRNSQ4 Update
3rd Jan 20237:00 amRNSAppointment of Liberum as Nominated Advisor
21st Nov 20227:00 amRNSPotash and Salt Offtake MOUs
27th Sep 20227:00 amRNSDirector/PDMR Shareholding
26th Sep 20221:45 pmRNSResults of REX Retail Offer & Total Voting Rights
26th Sep 20227:02 amRNSREX Retail Offer
26th Sep 20227:01 amRNSRenewal of Strategic Investment & Equity Placing
26th Sep 20227:00 amRNSInterim Results for the six months to 30 June 2022
16th Aug 20224:18 pmRNSExercise of Options & Director/PDMR Shareholding
22nd Jul 20229:00 amRNSShare Options Scheme & Director Shareholdings
19th Jul 20225:05 pmRNSReplacement: Director/PDMR Shareholding
18th Jul 20224:00 pmRNSDirector/PDMR Shareholding
11th Jul 20227:00 amRNSQ2 Activities Update
7th Jul 202212:30 pmRNSResult of AGM
20th Jun 20227:00 amRNSExercise of Warrants and Issue of Shares
13th Jun 20227:00 amRNSNotice of AGM and Posting of Annual Report
31st May 20227:00 amRNSAudited Results for the year ended 31 Dec 2021
31st Mar 20227:00 amRNSQ1 Activities Update
15th Mar 20227:00 amRNSGrant of Share Options
21st Feb 20227:00 amRNSAppointment of Chief Financial Officer
16th Feb 20227:00 amRNSAppointment of Corporate Broker
27th Jan 20227:00 amRNSBasic Engineering Packages Awarded to Reminex S.A
25th Jan 20221:00 pmRNSPart Exercise of Options and Issue of Shares
31st Dec 20217:00 amRNSEnd of Year Newsletter
6th Dec 202112:45 pmRNSResult of AGM
6th Dec 202112:31 pmRNSResult of General Meeting
2nd Dec 20217:00 amRNSOperational Update: Khemisset Potash Project
29th Nov 20217:00 amRNSDirector/PDMR Shareholding
24th Nov 20217:00 amRNSIssue of Equity & Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.